DC Field | Value | Language |
---|---|---|
dc.contributor.author | Y Oh | - |
dc.contributor.author | Lee Wha Gwon | - |
dc.contributor.author | H K Lee | - |
dc.contributor.author | J K Hur | - |
dc.contributor.author | Kwang Hyun Park | - |
dc.contributor.author | K P Kim | - |
dc.contributor.author | S H Lee | - |
dc.date.accessioned | 2024-07-19T16:33:20Z | - |
dc.date.available | 2024-07-19T16:33:20Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 0969-7128 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/35470 | - |
dc.description.abstract | The recently developed CRISPR activator (CRISPRa) system uses a CRISPR-Cas effector-based transcriptional activator to effectively control the expression of target genes without causing DNA damage. However, existing CRISPRa systems based on Cas9/Cas12a necessitate improvement in terms of efficacy and accuracy due to limitations associated with the CRISPR-Cas module itself. To overcome these limitations and effectively and accurately regulate gene expression, we developed an efficient CRISPRa system based on the small CRISPR-Cas effector Candidatus Woesearchaeota Cas12f (CWCas12f). By engineering the CRISPR-Cas module, linking activation domains, and using various combinations of linkers and nuclear localization signal sequences, the optimized eCWCas12f-VPR system enabled effective and target-specific regulation of gene expression compared with that using the existing CRISPRa system. The eCWCas12f-VPR system developed in this study has substantial potential for controlling the transcription of endogenous genes in living organisms and serves as a foundation for future gene therapy and biological research. | - |
dc.publisher | Springer-Nature Pub Group | - |
dc.title | Highly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system | - |
dc.title.alternative | Highly efficient and specific regulation of gene expression using enhanced CRISPR-Cas12f system | - |
dc.type | Article | - |
dc.citation.title | Gene Therapy | - |
dc.citation.number | 7 | - |
dc.citation.endPage | 365 | - |
dc.citation.startPage | 358 | - |
dc.citation.volume | 31 | - |
dc.contributor.affiliatedAuthor | Lee Wha Gwon | - |
dc.contributor.affiliatedAuthor | Kwang Hyun Park | - |
dc.contributor.alternativeName | 오윤선 | - |
dc.contributor.alternativeName | 권이화 | - |
dc.contributor.alternativeName | 이효민 | - |
dc.contributor.alternativeName | 허준호 | - |
dc.contributor.alternativeName | 박광현 | - |
dc.contributor.alternativeName | 김기표 | - |
dc.contributor.alternativeName | 이승환 | - |
dc.identifier.bibliographicCitation | Gene Therapy, vol. 31, no. 7, pp. 358-365 | - |
dc.identifier.doi | 10.1038/s41434-024-00458-w | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.